Huppert, L. A. Et Al. 2023. Systemic therapy for hormone receptor-positive/human epidermal growth factor receptor 2-negative early stage and metastatic breast cancer. CA-A CANCER JOURNAL FOR CLINICIANS , vol.73, no.5 , 480-515.

Huppert, L. A., Gümüşay, Ö., Idossa, D., & Rugo, H. S., (2023). Systemic therapy for hormone receptor-positive/human epidermal growth factor receptor 2-negative early stage and metastatic breast cancer. CA-A CANCER JOURNAL FOR CLINICIANS , vol.73, no.5, 480-515.

Huppert, Laura Et Al. "Systemic therapy for hormone receptor-positive/human epidermal growth factor receptor 2-negative early stage and metastatic breast cancer," CA-A CANCER JOURNAL FOR CLINICIANS , vol.73, no.5, 480-515, 2023

Huppert, Laura A. Et Al. "Systemic therapy for hormone receptor-positive/human epidermal growth factor receptor 2-negative early stage and metastatic breast cancer." CA-A CANCER JOURNAL FOR CLINICIANS , vol.73, no.5, pp.480-515, 2023

Huppert, L. A. Et Al. (2023) . "Systemic therapy for hormone receptor-positive/human epidermal growth factor receptor 2-negative early stage and metastatic breast cancer." CA-A CANCER JOURNAL FOR CLINICIANS , vol.73, no.5, pp.480-515.

@article{article, author={Laura A. Huppert Et Al. }, title={Systemic therapy for hormone receptor-positive/human epidermal growth factor receptor 2-negative early stage and metastatic breast cancer}, journal={CA-A CANCER JOURNAL FOR CLINICIANS}, year=2023, pages={480-515} }